Document is current
Any future updates will be listed below
-
Authors
Markakis, Demi https://orcid.org/0000-0002-8266-3769
Britten-Jones, Alexis Ceecee https://orcid.org/0000-0002-1101-2870
Guymer, Robyn H. https://orcid.org/0000-0002-9441-4356
Edwards, Thomas L. https://orcid.org/0000-0003-0238-7416
Hall, Anthony J. https://orcid.org/0000-0003-1760-3759
Kerr, Nathan M. https://orcid.org/0000-0001-7381-285X
Ng, Weng https://orcid.org/0009-0008-0526-9371
Skalicky, Simon https://orcid.org/0000-0001-8022-8002
Ayton, Lauren N. https://orcid.org/0000-0001-9907-084X
Mack, Heather G. https://orcid.org/0000-0001-9756-1098
-
Funding
Funding for this research was provided by:
Cabrini Medical Staff Scholarship
University of Melbourne (Postdoctoral Scholarship, Driving Research Momentum Fellowship)
State Government of Victoria (Operational Infrastructure Support Program, Operational Infrastructure Support Program, Operational Infrastructure Support Program, Operational Infrastructure Support Program)
National Health and Medical Research Council (1195713)
- License Information
-
More Information
Article History
Received: 15 December 2024
Accepted: 13 February 2025
First Online: 12 March 2025
Declarations
:
: L.N.A. has been a consultant to Novartis and Apellis Pharmaceuticals and currently consults for Kiora Pharmaceuticals. T.L.E. has received a research grant from Novartis Pharmaceuticals. R.H.G. is a member of advisory boards of Bayer, Novartis, Apellis Pharmaceuticals, Roche-Genentech, Belite Bio, Ocular therapeutix, complement therapeutics, Boehringer Ingelheim Pharmaceuticals, Character Bioscience, Janssen, AbbVie and Astellas. A.J.H. is a member of an advisory board for AbbVie, receives research support from Novotech, Genentech and Roche and is a paid lecturer for UCB. N.M.K. has received research funding and/or honoraria from Alcon, Allergan/Abbvie, Bayer, Glaukos, Johnson & Johnson Vision, NOVA Eye Medical, Santen, and VividWhite. H.G.M. has been a member of advisory boards of Novartis, Apellis Pharmaceuticals, Roche-Genentech and Janssen Pharmaceuticals, and has received travel funding from Bayer and Roche-Genentech. S.S. is the director of Eyeonic Pty Ltd which owns patent WO2021051162A1 regarding online circular contrast perimetry. The remaining authors report no conflicts of interest in this work.
